Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. - Wikidata - wikimedia - TriplyDB

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

http://www.wikidata.org/entity/Q37219764

about

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Beta-amyloid deposition and the aging brain PET amyloid-beta imaging in preclinical Alzheimer's disease Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.Recent advances in imaging Alzheimer's disease.Brain imaging in the study of Alzheimer's disease Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.Exercise and Alzheimer's disease biomarkers in cognitively normal older adults.Family history and APOE-4 genetic risk in Alzheimer's disease.Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.Neurogenetic effects on cognition in aging brains: a window of opportunity for intervention?APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42 Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry Neuroimaging measures as endophenotypes in Alzheimer's disease Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism.Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.Brain network local interconnectivity loss in aging APOE-4 allele carriers Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Prediction of cognitive decline by positron emission tomography of brain amyloid and tau.Decreased cognitive function in extended family members from the single late-onset-Alzheimer's-disease pedigree Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease.Vascular risk and FDDNP-PET influence cognitive performance.Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease.PET/CT in diagnosis of dementia Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.Response to Letter from Shin and Lee, entitled "FDDNP PET patterns in nondemented populations"Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline.Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.

P2860

Q24604376-24B807C9-4B9E-457E-A3A5-74CC92BB2274 Q28264556-3AFD314E-54C8-4F8D-9938-80DFD1145DA3 Q30040695-58BA281E-49DA-46E6-9285-E75C643D4EFA Q30845482-67E0A815-F744-45E2-AAE0-F2F3973797B3 Q33695738-5C06627A-3392-4BE4-A9B5-811513805AF6 Q33773031-3E65062B-CC5C-4A50-BCCF-C893E8EC240E Q33798453-D0F83642-8778-4D4B-A25C-794028BEF900 Q33946440-BB346DFD-0C9D-43C7-9D29-C92163FB5A35 Q34102331-F7B35309-3EEE-464A-AD88-9D90591BECE9 Q34102715-604D38D3-0641-4F0E-A167-BBE64CDFD607 Q34116194-8BBD5FC9-2DE0-43AB-83AB-71C014FBCDED Q34167647-40DEE9ED-9F63-464B-AEAB-743B2476DB06 Q34303501-2D1FE394-0D47-45BC-A614-003E9BFF1053 Q34329836-04908D5B-E127-47D2-AC81-E13A1F656FBC Q34501648-873C4C37-55DF-4967-B329-A45C81759A83 Q34615211-2E890932-8C5D-422B-B63E-26FB9EC6E8BD Q34924165-4AB0DCB5-F197-4A0B-B522-47E59F419492 Q35055317-E4A55F74-7052-45C7-83BA-D7C3C4A738AC Q35224265-C8987640-DCAC-4234-B5B3-97AA65F983B9 Q35651340-8717EF7C-E9D9-4ED4-B03F-CEC8243D99A1 Q35681808-B15BC671-12DF-42CD-B9C1-4618F7B2A8E1 Q35825830-B709B0CD-D2C0-4A40-96C4-5AE883650462 Q36526176-7B164D1A-2FFB-4B96-BD4C-08816B893987 Q36759184-6C64111A-74FE-4243-B307-B88FAFA03B3A Q37073537-236E2ADF-5B06-4A23-BD5A-075C6D662E28 Q37112001-4AA737ED-FE9C-4145-AFEF-E683AA511350 Q37365099-77356D8A-E414-4CCB-9AEB-D24DE1A09EAA Q37417513-9294B683-C4E7-4E30-BC72-E9D8DAB99A0A Q37445869-555E36D1-2DC6-4B21-8864-664378DFF15A Q37772498-05FA50B0-A064-4033-8E9F-33D5987BC8C2 Q37896141-BC134080-FF8A-418A-9682-1DDF05AB2165 Q38969008-7222C68F-33A2-4FD8-A057-18603A634FF1 Q41855014-23994FFE-E572-482B-80C7-E4EF0967CDB8 Q43120876-5CAF35E0-F778-46EF-A5A2-86122CA9FEB1 Q44793917-AEC4D6D9-5919-4419-A76A-33947CC53DE9

P2860

Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.

http://www.wikidata.org/entity/Q37219764

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Influence of cognitive status, ...... g in persons without dementia.

@en

Influence of cognitive status, ...... g in persons without dementia.

@nl

type

label

Influence of cognitive status, ...... g in persons without dementia.

@en

Influence of cognitive status, ...... g in persons without dementia.

@nl

prefLabel

Influence of cognitive status, ...... g in persons without dementia.

@en

Influence of cognitive status, ...... g in persons without dementia.

@nl

P1433

Q37219764-01B8B473-44CD-4451-9A2F-8EE0116F9258

P1476

Q37219764-3CDD21AB-6B90-44E1-900F-30A750731E4A

P2093

Q37219764-00AF912F-95FB-450A-BA91-AAF4EA76325B

Q37219764-30DF57FA-6EB2-49B3-9C0D-B23DC34FF016

Q37219764-4EC80DD9-873F-48F4-8683-79243BA8DB90

Q37219764-52FA4A6F-D3EA-41C7-97B5-BCAF42C5B0B0

Q37219764-7DCB719B-77ED-4EDB-9490-966645C4D38C

Q37219764-7F92E42A-82FF-4506-B94D-AA4164121D96

Q37219764-93EAD430-88BE-4FBF-BD51-EE30EA0ED304

Q37219764-A1178C9D-3ABF-45DC-B3DE-D9C2E7EA7ADE

Q37219764-C5416479-E5A4-4075-B3C7-BDAF98564735

Q37219764-EE7A2FA8-D0B0-41F6-B784-82DBE6B7975D

P2860

Q37219764-02F7958F-03D3-42DA-A765-9F43AF65F82E

Q37219764-19F1699E-5167-4613-9972-CAE44B26D7CF

Q37219764-1F724368-74BF-45E4-B386-B2077B873B51

Q37219764-225160FC-7318-4E29-A512-13A1FE7C2DD0

Q37219764-268A0D97-F016-4FBC-99B3-0A0AB5A36809

Q37219764-34275068-69D4-4AC3-9CBD-03206BE7F319

Q37219764-387C657C-A1EE-4B79-8CC2-F0577928D9D1

Q37219764-3D063A9D-6CF0-4B41-B8FE-3AAEFBF0727F

Q37219764-4971C1AE-CF67-40FE-B0B6-34C8F088ED46

Q37219764-49CD762B-1EAF-4CC2-B4C2-DB9CAFE3FB06

P304

Q37219764-CAA289A4-C4EE-4E40-833C-BAF7E46ACA95

P31

Q37219764-0E552999-7138-4B9D-B173-65211BFCDB18

P356

Q37219764-E9E85FF4-1353-492B-ABFE-04F72A402B2C

P407

Q37219764-CCF176FA-7526-42C1-AC24-6185035FBE5D

P433

Q37219764-F8FD8A1A-8A5D-4A06-908E-A09028485A45

P478

Q37219764-5DA1A861-3147-455B-B8D7-C6CE83561537

P50

Q37219764-38C0F74B-F3EB-4025-A3E4-919F1B36D7F3

Q37219764-A9899DC9-486C-4A37-B5C0-E89A885459D6

Q37219764-C92690F7-A3D7-4545-90A6-7A32130D0EC9

P577

Q37219764-3F0F1D78-B19F-43AA-A200-36BC1B0AD657

P5875

Q37219764-59348886-105D-46C5-A2CB-16DF489C23B5

P698

Q37219764-D6C0173E-B2CD-4993-8997-F84DC53C9A80

P921

Q37219764-15C7054A-5102-4209-B73D-EA0C566EA7FC

P932

Q37219764-CDD2C504-0415-4957-9155-CB94A3BBF85B

P356

ARCHGENPSYCHIATRY.2008.516

P1433

JAMA Psychiatry

P1476

Influence of cognitive status, ...... g in persons without dementia.

@en

P2093

Alison C Burggren

http://www.w3.org/2001/XMLSchema#string

Gary W Small

http://www.w3.org/2001/XMLSchema#string

Greg M Cole

http://www.w3.org/2001/XMLSchema#string

Jorge R Barrio

http://www.w3.org/2001/XMLSchema#string

Karen J Miller

http://www.w3.org/2001/XMLSchema#string

Linda M Ercoli

http://www.w3.org/2001/XMLSchema#string

Michael E Phelps

http://www.w3.org/2001/XMLSchema#string

Prabha Siddarth

http://www.w3.org/2001/XMLSchema#string

S C Huang

http://www.w3.org/2001/XMLSchema#string

Vladimir Kepe

http://www.w3.org/2001/XMLSchema#string

P2860

What we need to know about age related memory loss

A rating scale for depression

“Mini-mental state”

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

Neuropathologic features of amnestic mild cognitive impairment

Influence of education and occupation on the incidence of Alzheimer's disease

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

P304

81-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHGENPSYCHIATRY.2008.516

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Paul M. Thompson

Susan Y Bookheimer

Helen Lavretsky

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23759733

http://www.w3.org/2001/XMLSchema#string

P698

19124691

http://www.w3.org/2001/XMLSchema#string

P921

P932

2693405

http://www.w3.org/2001/XMLSchema#string